2022 •
An Antiviral Formulation with RNA Dependent RNA Polymerase and Ribonucleotide Reductase Suppressive Features Exhibiting Protopanaxatriol Class Glucopyranoside Analouges for The Treatment of Coronaviral & Adenoviral Infections
Authors: Alkoclar, Erdal
Venue: N/A
Type: Publication
Abstract: An Antiviral Formulation that exerts RNA Dependent RNA Polymerase and Ribonucleotide Reductase Suppressive Features. Consisting of 3 Protopanaxtriol - Class Glucopyranoside Analouges and a Flavonol Glycoside Derivative , Formulation Exhibits Potent Antiviral Effects Regarding the Adjunctive Treatment of Coronaviral and Adenoviral Infections. Inventors: Erdal Can ALKOCLAR & Metehan YESIL
Popularity: This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the
underlying citation network.
Influence: This indicator reflects the overall/total impact of an article in the research community at large, based on the
underlying citation network (diachronically).
Citation Count: This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in
the research community at large, based on the underlying citation network (diachronically).
Impulse: This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation
network.
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more